Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic

Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic

Objective: We studied whether the use of hydroxychloroquine (HCQ) for COVID‐19 resulted in supply shortages for patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Methods: We used US claims data (IQVIA PHARMETRICS® Plus for Academics [PHARMETRICS]) and hospital electroni...

全面介绍

书目详细资料
Main Authors: Mercadé‐Besora, N, Guo, Y, Du, M, Li, X, Ramírez‐Anguita, JM, Moreno, A, Valente, A, Villalobos, F, Cheng, IL, Carrasco‐Ribelles, LA, van Swieten, MMH, Merkelbach, M, Magoya, M, Lasalvia, P, Pericàs‐Pulido, P, Berg, P, Bosco‐Lévy, P, Lillini, R, Ribeiro, R, Bagga, TK, Ramella, V, Khalid, S, Mayer, MA, Leis, A, Jödicke, AM, Burn, E, Prieto‐Alhambra, D, Català, M, Prats‐Uribe, A
格式: Journal article
语言:English
出版: Wiley 2024

相似书籍